The Dozee device can help doctors remotely check on patients’ progress and flag off possible deteriorations well in advance
Bengaluru, NFAPost: Dozee, a contact-free heartbeat and respiration monitor that has medical-grade (98.4%) accuracy. has announced an offering of free devices to those quarantined within Bangalore city limits.
It is a device that gives continuous respiration data, that too without the need for wires or even any technical expertise. Dozee is a portable device attached to a thin sensor sheet which goes below the mattress, to be kept right underneath the patient’s chest area.
This initiative is supported by Duroflex, a leading sleep solutions brand with over five decades of expertise in making premium mattresses and sleep accessories.
The idea behind this activity is to proactively help those in need and at risk in this crucial hour. Particularly since, respiratory ailments are one of the symptoms of the ongoing COVID19 pandemic. The Dozee device can help doctors remotely check on patients’ progress and flag off possible deteriorations well in advance.
As the healthcare system and research labs work tirelessly towards finding a solution to this sudden outbreak, the team’s aim is to ease their burden and risk by providing a dependable and non-intrusive solution to the monitoring vital signs. This will also help ease anxiety of loved ones’ as currently they have limited means to know the health status of those quarantined at home.
Launched in mid-2019, Dozee is available on both Amazon.in & its website, Dozee has also been backed by reputed companies like Qualcomm and Department of Biotechnology – Govt of India – BIRAC and Bill & Melinda Gates Foundation for product development and acceleration.
This Bengaluru based healthcare startup is the brainchild of IIT alumni Mudit Dandwate and Gaurav Parchani. Commenting on the initiaitve, Dozee CEO Mudit Dandwate said this initiative will help Bengaluru residents to monitor their health on an ongoing basis in the comfort of their homes.
“This is enabling care at home, unlocking the value of telemedicine and reducing pressure on our healthcare system. Our aim is to be a health companion to all Indians and this is a small step towards the residents facing a lockdown in Bangalore. Continuing our objective we are closely working with NGOs, hotels, hospitals to create step-down ICU set up using Dozee,” said Dozee CEO Mudit Dandwate.
Sleep Evangelist and Duroflex Managing Director Mathew Chandy said the company is a deeply invested in providing our consumers with innovative sleep solutions.
“In daunting times like these, the well-being of our consumers is our top priority. Along with the measures taken by us at a company level, we are excited to partner with Dozee to offer free health monitoring devices to help quarantined residents in Bangalore monitor their progress during this pandemic. With this common goal in mind, we hope to help consumers keep track of their health while at home and help them sleep better,” said Sleep Evangelist and Duroflex Managing Director Mathew Chandy.
Turtle Shell Technologies Pvt Ltd (TST) which operates Dozee started its operation in 2015. The Indian health- tech company is the first one to launch a contactless health companion under the brand Dozee in India.
Dozee uses Ballistocardiography as the underlying technology where a thin sensor sheet is placed below the mattress (any mattress up to 18 inch) of the user to capture the data on micro vibrations in the human body.
This data of micro vibration is further analyzed using advanced machine learning and artificial intelligence algorithms to create health data about the user. Dozee is used for proactive health monitoring of health for preventive health care, stress management, sleep improvement and athlete performance management.
TST also provided their technology for smart mattresses. Dozee was awarded Best Healthcare Startup at Bioasia 2019 and Best Tech Innovation at Assocham 2019. They have developed their technology in close collaboration with NIMHANS, Jayadeva Institute of Cardiac Sciences.